CLINICAL_TRIALS
trial_result
· 2013-12-25
Clinical Trial Update: A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer [Phase 2]
Summary
Phase 2 trial update evaluating pemetrexed with bevacizumab in advanced non-small cell lung cancer. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-12-25